Elevance Health, Inc.
ELV
$317.20
-$4.75-1.48%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.79% | -19.89% | -5.24% | -0.12% | 7.04% |
| Total Depreciation and Amortization | 9.54% | -10.23% | -24.54% | -37.83% | -38.58% |
| Total Amortization of Deferred Charges | 7.15% | 7.15% | 7.15% | 7.15% | 14.36% |
| Total Other Non-Cash Items | 74.36% | -58.59% | -99.15% | -82.18% | -66.28% |
| Change in Net Operating Assets | 54.25% | 89.01% | 54.89% | -221.31% | -986.82% |
| Cash from Operations | 130.50% | 212.24% | 35.77% | -27.95% | -77.60% |
| Capital Expenditure | 9.13% | 10.43% | 7.93% | 3.09% | 0.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -233.18% | -259.51% | -256.77% | -209.86% | 30.70% |
| Divestitures | -95.24% | -95.49% | -- | -- | -- |
| Other Investing Activities | 152.68% | 172.74% | 172.85% | 119.64% | -86.40% |
| Cash from Investing | 24.40% | 45.85% | 41.38% | 7.27% | -7.15% |
| Total Debt Issued | 194.31% | 90.86% | 360.60% | 174.12% | -24.49% |
| Total Debt Repaid | -771.53% | -1,749.72% | -656.81% | -10.97% | 86.19% |
| Issuance of Common Stock | -84.08% | -61.84% | -28.64% | 45.39% | 72.54% |
| Repurchase of Common Stock | -87.52% | -25.34% | -22.97% | -8.43% | 12.16% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.97% | -4.89% | -6.47% | -8.10% | -9.38% |
| Other Financing Activities | -72.73% | -270.00% | -277.78% | -71.43% | -63.33% |
| Cash from Financing | 7.06% | -150.58% | 73.15% | 135.62% | 81.05% |
| Foreign Exchange rate Adjustments | -333.33% | 112.50% | -150.00% | -500.00% | -- |
| Miscellaneous Cash Flow Adjustments | -130.00% | -114.29% | -- | -- | -- |
| Net Change in Cash | 127.74% | 159.04% | 132.53% | 304.65% | -249.15% |